Company intelligence
FreeMind Group
Helping life science companies win non-dilutive funds from US federal agencies & private foundations to fund their R&D
About FreeMind Group
We're celebrating our 25th anniversary! Established in 1999, the FreeMind Group mission is to assist life science organizations secure non-dilutive funding from US federal agencies and private foundations to fund R&D. For each project in our client’s pipeline, we provide a robust, long-term, multi-submission granting strategy. Our team is well versed in the interests, goals, and available funding opportunities of each funding source. Combining their extraordinary scientific understandings, innovative business and financial expertise, and writing and presentation skills, our team works with each of our clients to understand and cater to their specific needs. Every year, we secure for our clients over $100 million annually in non-dilutive funding! Check us out 👉 www.freemindconsultants.com Questions? 👉 michals@freemindconsultants.com
Verified activity
Signals from FreeMind Group
6 published signals
Presence & Recognition
FreeMind Group announced the 22nd Annual Non-Dilutive Funding Summit taking place on January 13, 2027 during J.P. Morgan Healthcare Week in San Francisco.
Reported by FreeMind Group
Presence & Recognition
FreeMind Group is hosting the BioFuture event in New York City from October 27-28, 2026.
Reported by FreeMind Group
Presence & Recognition
FreeMind Group is a supporter of the 26th Annual Biotech in Europe Forum by Sachs Associates, which will take place on the 7th to 8th of October 2026 at the Mövenpick Hotel Basel.
Reported by FreeMind Group
Presence & Recognition
FreeMind Group is attending LSX USA Congress by Informa in Boston from September 22-24, 2026.
Reported by FreeMind Group
Research & Knowledge
FreeMind Group published a new solicitation from the National Institute of Neurological Disorders and Stroke (NINDS) for investigator-initiated clinical trials.
Reported by FreeMind Group
Presence & Recognition
FreeMind Group congratulated client Neomorph, Inc. on their Biomedical Advanced Research and Development Authority (BARDA) award.
Reported by FreeMind Group